Hiroko Ishida - Concepedia

Concepedia

Author

Hiroko Ishida

Daiichi University of Pharmacy

Also Known As

H Ishida, H. Ishida, Hiroko ISHIDA, Hiroko Ishida

48

Publications

2.3K

Citations

18

H-Index

34

Concepts

All Affiliations

Daiichi University of Pharmacy Essential Research (United States)Hiroshima University The University of Tokyo Daiichi-Sankyo (Japan)

HI

About

Hiroko Ishida is an author at Daiichi University of Pharmacy specializing in medicine, antimicrobial resistance, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	675
2	Health Sciences	6	6	359
3	Natural Sciences	3	3	208
4	Biochemistry	3	3	85
5	Cell Biology	1	1	153

Hiroko Ishida

×

20

Publications

2.3K

Citations

18

H-Index

	Year	Citations
Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in <i>Pseudomonas aeruginosa</i> : Novel Agents for Combination Therapy Olga Lomovskaya, Mark S. Warren, Angela Lee, Antimicrobial Agents and Chemotherapy	2001	877
Interplay between Efflux Pumps May Provide Either Additive or Multiplicative Effects on Drug Resistance Angela Lee, Weimin Mao, Mark S. Warren, Journal of Bacteriology	2000	263
Use of a Genetic Approach To Evaluate the Consequences of Inhibition of Efflux Pumps in <i>Pseudomonas aeruginosa</i> Olga Lomovskaya, Angela Lee, Kazuki Hoshino, Antimicrobial Agents and Chemotherapy	1999	216
Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen1The nucleotide sequence data reported in this paper will appear in the EMBL, GenBank and DDBJ Nucleotide Sequence Databases under the accession number D55717.1 Mitsuhide Noshiro, Shigeru Ohno, Takeshi Kawamoto, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Connective Tissue DiseaseNatural SciencesCartilage DegenerationMolecular BiologyAccession Number D55717.1	1997	153
In Vitro and In Vivo Activities of Levofloxacin against Biofilm-Producing <i>Pseudomonas aeruginosa</i> Hiroko Ishida, Yoshihisa Ishida, Yuichi Kurosaka, Antimicrobial Agents and Chemotherapy Biofilm CellsAntimicrobial ChemotherapyBiofilm BacteriaDrug ResistanceVivo Activities	1998	142
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies Hiroaki Kitaoka, Hiroyuki Tsutsui, Toru Kubo, Circulation Journal	2021	103
MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization Kiyoshi Nakayama, Yohei Ishida, Masami Ohtsuka, Bioorganic & Medicinal Chemistry Letters Early StrategiesAntimicrobial SusceptibilityHealth SciencesAntibioticsLead Identification	2003	82
Molecular Cloning and Expression of Rabbit Sterol 12α-Hydroxylase Gösta Eggertsen, Maria Olin, Hiroko Ishida, Journal of Biological Chemistry	1996	68
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model Kiyoshi Nakayama, Haruko C. Kawato, Jun Watanabe, Bioorganic & Medicinal Chemistry Letters Pyridopyrimidine SeriesAntimicrobial SusceptibilityMedicinePseudomonas AeruginosaAntibacterial Agent	2003	65
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds Kiyoshi Nakayama, Yohei Ishida, Masami Ohtsuka, Bioorganic & Medicinal Chemistry Letters Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineAchieving Activity	2003	58

Page 1